OAC
SPRB

OMERS Administration Corp’s Spruce Biosciences SPRB Stock Holding History

OMERS Administration Corp’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-213
Closed -$12.6K – 1231
2024
Q1 		$12.6K Buy
+213
New +$54.2K ﹤0.01% 390

Other funds holding SPRB

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

OMERS Administration Corp's SPRB Position: Q2 2024 in Review

OMERS Administration Corp sold out of Spruce Biosciences (SPRB) in Q2 2024, closing a stake of 213 shares — an estimated $12.6K sold.

OMERS Administration Corp first reported a position in SPRB in Q1 2024 and held it in 1 quarter. The position peaked at $12.6K in Q1 2024. 37 funds tracked by Wall St. Rank hold SPRB as of Q2 2024.

  • OMERS Administration Corp reported no remaining Spruce Biosciences position as of Q2 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 213 Spruce Biosciences shares in Q2 2024, an estimated $12.6K.
  • OMERS Administration Corp first reported a position in Spruce Biosciences in Q1 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Spruce Biosciences position peaked at $12.6K in Q1 2024.
  • 37 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2024.

Based on OMERS Administration Corp's 13F filing for Q2 2024, filed 13 Aug 2024.